Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000282417 | SCV000337139 | likely benign | not specified | 2018-09-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000282417 | SCV000615342 | benign | not specified | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000875359 | SCV001017673 | likely benign | Facioscapulohumeral muscular dystrophy 2 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001753745 | SCV001987301 | benign | not provided | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001753745 | SCV005214840 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003967736 | SCV004781921 | likely benign | SMCHD1-related disorder | 2019-04-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |